Results 231 to 240 of about 48,457 (271)

Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti–Melanoma Differentiation–Associated Protein 5 Positivity

Arthritis & Rheumatology, 2022
This study aimed to evaluate whether the 2017 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIMs) could appropriately ...
H. So, J. So, T. Lam, V. Wong, R. Ho, Wai Ling Li, C. Mok, C. S. Lau, L. Tam   +8 more
semanticscholar   +1 more source

Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis.

Rheumatology, 2021
OBJECTIVES Diagnosing the idiopathic inflammatory myopathies (IIMs) can be challenging as several conditions, including genetic myopathies such as limb girdle muscular dystrophy type R12 (LGMD 2 l, anoctaminopathy), mimic the presentation.
Italo Marago, M. Roberts, F. Roncaroli, D. Duplessis, C. Sewry, S. Nagaraju, Faheema Limbada, C. Marini-Bettolo, J. Hudson, Siwalik Banerjee, L. Newton, M. Bukhari, H. Chinoy, J. Lilleker   +13 more
semanticscholar   +1 more source

Performance of myositis‐specific antibodies detected on myositis line immunoassay to diagnose and sub‐classify patients with suspected idiopathic inflammatory myopathy, a retrospective records‐based review

International Journal of Rheumatic Diseases, 2021
To evaluate myositis line immunoassay (LIA) for diagnosis and sub‐classification of suspected idiopathic inflammatory myopathy (IIM). To investigate if test performance is improved by increasing signal strength cut‐off for myositis‐specific antibody (MSA)
T. Beaton, D. Gillis, Kerri M. Prain, Karen Morwood, James Anderson, J. Goddard, T. Baird   +6 more
semanticscholar   +1 more source

Distinct Expression of Coinhibitory Molecules on Alveolar T Cells in Patients With Rheumatoid Arthritis–Associated and Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease

Arthritis & Rheumatology, 2020
To identify immunologic factors in the lungs of patients with rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) and patients with idiopathic inflammatory myopathy–associated ILD (IIM‐ILD) and to examine their pathologic mechanisms.
M. Nakazawa, Katsuya Suzuki, M. Takeshita, J. Inamo, H. Kamata, M. Ishii, Y. Oyamada, H. Oshima, T. Takeuchi   +8 more
semanticscholar   +1 more source

The diagnostic value of GDF-15 for myocardial involvement in idiopathic inflammatory myopathy.

Rheumatology, 2020
BACKGROUND Cardiac involvement is a serious complication of idiopathic inflammatory myopathy (IIM). GDF-15 can predict the risk and the prognosis of cardiovascular disease, but its value is unclear in IIM.
M. Qiu, Xiaoxuan Sun, Xiaoqing Qi, Xianfang Liu, Yue Zhang, Ning Zhang, F. Lu, Wangyan Liu, Changjing Feng, Qiang Wang, Lei Zhou   +10 more
semanticscholar   +1 more source

Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study.

Rheumatology, 2019
OBJECTIVE Post-hoc analyses of the Rituximab in Myositis trial indicate that specific autoantibodies profiles may influence treatment response. We compared the efficacy and safety of rituximab in anti-synthetase antibody (ARS-ab) positive and negative ...
V. Leclair, A. Galindo-Feria, M. Dastmalchi, M. Holmqvist, I. Lundberg   +4 more
semanticscholar   +1 more source

CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease

Rheumatology, 2018
BACKGROUD There is an unmet need for the development of new biomarkers for idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD).
Kaiwen Wang, Jiangfeng Zhao, Zhiwei Chen, Ting Li, Xiaoming Tan, Yu Zheng, Liyang Gu, Li Guo, F. Sun, Haiting Wang, Jiajie Li, Xiaodong Wang, G. Riemekasten, S. Ye   +13 more
semanticscholar   +1 more source

Aberrant expansion of circulating CD4+CXCR5+CCR7loPD1hi Tfh precursor cells in idiopathic inflammatory myopathy

International Journal of Rheumatic Diseases, 2019
To determine circulating follicular T helper (Tfh) cell precursor and its relationship with clinical characteristics in idiopathic inflammatory myopathy (IIM).
Lu Zhang, Wenli Li, Ying Cai, Xia Liu, Q. Peng, Lin Liang   +5 more
semanticscholar   +1 more source

Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset

Arthritis care & research, 2018
To assess the incidence of venous thromboembolic events (VTEs) in patients with idiopathic inflammatory myopathies (IIMs), to compare the incidence of VTEs in IIM to the incidence in the general population, and to identify patient categories at high risk
A. Antovic, A. Notarnicola, J. Svensson, I. Lundberg, M. Holmqvist   +4 more
semanticscholar   +1 more source

Bibliometric and altmetric analyses of publication activity in the field of idiopathic inflammatory myopathy in 2011–2021 based on web of science core collection databases

Rheumatology International, 2022
Mengxiang Li, Feng Yin, Youxian He, Xue Zhang, Hao Yu, Qiuyu Yang, Xintong Xie, Guangliang Wei, Huidong Chen, Chengsong He, Yue He, Jie Chen   +11 more
semanticscholar   +1 more source